Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gauri R Varadhachary

Showing results (91-100 of 113) with videos related to

Pageof 12
Sort By:
Cancer|June 1, 2016
Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinomaJordan M Cloyd, Christopher H Crane, Eugene J Koay, et al.
Oncotarget|November 21, 2017
Outcomes of phase I clinical trials for patients with advanced pancreatic cancer: update of the MD Anderson Cancer Center experienceJennifer B Goldstein, Chad Tang, Kenneth R Hess, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 19, 2013
Treatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on multimodality therapy completion and survivalChing-Wei D Tzeng, Hop S Tran Cao, Jeffrey E Lee, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 19, 2018
Physical activity and exercise during preoperative pancreatic cancer treatmentNathan H Parker, An Ngo-Huang, Rebecca E Lee, et al.
International Journal of Radiation Oncology, Biology, Physics|January 10, 2017
Does Unintentional Splenic Radiation Predict Outcomes After Pancreatic Cancer Radiation Therapy?Awalpreet S Chadha, Guan Liu, Hsiang-Chun Chen, et al.
Annals of Surgical Oncology|January 27, 2017
Influence of Preoperative Therapy on Short- and Long-Term Outcomes of Patients with Adenocarcinoma of the Ampulla of VaterJordan M Cloyd, Huamin Wang, Michael Overman, et al.
Cancer Medicine|July 12, 2021
Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patientsChirayu Mohindroo, Merve Hasanov, Jane E Rogers, et al.
Journal of the National Cancer Institute|May 18, 2023
Feasibility and value of genomic profiling in cancer of unknown primary: real-world evidence from prospective profiling studyRyan W Huey, Aakash Tushar Shah, Honey V Reddi, et al.
Plos One|June 24, 2016
Phase I Trial of Consolidative Radiotherapy with Concurrent Bevacizumab, Erlotinib and Capecitabine for Unresectable Pancreatic CancerAwalpreet S Chadha, Heath D Skinner, Jillian R Gunther, et al.
Journal for Immunotherapy of Cancer|December 1, 2023
Multicenter randomized controlled trial of neoadjuvant chemoradiotherapy alone or in combination with pembrolizumab in patients with resectable or borderline resectable pancreatic adenocarcinomaMatthew H G Katz, Gina R Petroni, Todd Bauer, et al.
Pageof 12

Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
Cancer|June 1, 2016
Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinomaJordan M Cloyd, Christopher H Crane, Eugene J Koay, et al.
Oncotarget|November 21, 2017
Outcomes of phase I clinical trials for patients with advanced pancreatic cancer: update of the MD Anderson Cancer Center experienceJennifer B Goldstein, Chad Tang, Kenneth R Hess, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 19, 2013
Treatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on multimodality therapy completion and survivalChing-Wei D Tzeng, Hop S Tran Cao, Jeffrey E Lee, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 19, 2018
Physical activity and exercise during preoperative pancreatic cancer treatmentNathan H Parker, An Ngo-Huang, Rebecca E Lee, et al.
International Journal of Radiation Oncology, Biology, Physics|January 10, 2017
Does Unintentional Splenic Radiation Predict Outcomes After Pancreatic Cancer Radiation Therapy?Awalpreet S Chadha, Guan Liu, Hsiang-Chun Chen, et al.
Annals of Surgical Oncology|January 27, 2017
Influence of Preoperative Therapy on Short- and Long-Term Outcomes of Patients with Adenocarcinoma of the Ampulla of VaterJordan M Cloyd, Huamin Wang, Michael Overman, et al.
Cancer Medicine|July 12, 2021
Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patientsChirayu Mohindroo, Merve Hasanov, Jane E Rogers, et al.
Journal of the National Cancer Institute|May 18, 2023
Feasibility and value of genomic profiling in cancer of unknown primary: real-world evidence from prospective profiling studyRyan W Huey, Aakash Tushar Shah, Honey V Reddi, et al.
Plos One|June 24, 2016
Phase I Trial of Consolidative Radiotherapy with Concurrent Bevacizumab, Erlotinib and Capecitabine for Unresectable Pancreatic CancerAwalpreet S Chadha, Heath D Skinner, Jillian R Gunther, et al.
Journal for Immunotherapy of Cancer|December 1, 2023
Multicenter randomized controlled trial of neoadjuvant chemoradiotherapy alone or in combination with pembrolizumab in patients with resectable or borderline resectable pancreatic adenocarcinomaMatthew H G Katz, Gina R Petroni, Todd Bauer, et al.
Pageof 12